Actionnariat et activité des initiés pour Oncolytics Biotech Inc. (ONCY): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.77 |
| Capitalisation | $77M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-01 | McAdory John Bearden | 500,000 | $485K | |
| 2026-06-01 | Glover Stephen C. | |||
| 2026-03-11 | Parsons James T. | P-Purchase | 10,000 | $10K |
| 2026-03-12 | Kelly Jared | P-Purchase | 5,050 | $5K |
| 2026-02-12 | Kelly Jared | P-Purchase | 29,500 | $25K |
| 2026-02-11 | Kelly Jared | P-Purchase | 5,600 | $5K |
| 2026-02-12 | Look Kirk | P-Purchase | 12,000 | $10K |
| 2026-02-12 | Pisano Wayne | P-Purchase | 30,000 | $25K |
| 2026-02-12 | Heineman Thomas Charles | P-Purchase | 12,132 | $10K |
| 2026-02-12 | Brown Deborah Margaret | P-Purchase | 25,000 | $21K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $12.0M | $11.8M | $13.7M | $14.1M | $31.2M | $41.3M | $11.7M | $34.9M | $15.9M | $7.1M |
| Placements à Court Terme | $2.1M | 0 | 0 | 0 | 0 | 0 | $20.5M | 0 | 0 | 0 |
| Créances | $54406 | $4.8M | $51650 | 0 | 0 | $866000 | $521000 | $15000 | $68000 | $786230 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $14.4M | $17.8M | $14.5M | $18.9M | $33.7M | $44.9M | $35.7M | $38.2M | $18.9M | $9.4M |
| Immobilisations Corporelles | $319955 | $333441 | $412736 | $727481 | $609132 | $976000 | $652000 | $647000 | $1.3M | $1.0M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $14.8M | $18.2M | $14.9M | $19.7M | $34.3M | $45.9M | $37.3M | $38.8M | $20.2M | $10.4M |
| Dettes Fournisseurs | $4.1M | $3.5M | $1.8M | $3.2M | $1.8M | $594000 | $2.3M | $1.1M | $1.1M | $4.8M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $4.1M | $5.2M | $2.8M | $12.9M | $2.7M | $2.7M | $3.9M | $4.2M | $6.7M | $8.4M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $4.1M | $9.9M | $8.7M | $19.8M | $9.6M | $9.8M | $10.8M | $11.3M | $14.2M | $15.6M |
| Réserves | -$278.8M | -$294.4M | -$311.5M | -$344.6M | -$367.1M | -$393.4M | -$418.3M | -$446.0M | -$477.7M | -$589.3M |
| Capitaux Propres | $10.7M | $8.3M | $6.2M | -$107894 | $24.8M | $36.1M | $26.5M | $27.6M | $6.0M | -$5.2M |
| Dette Totale | 0 | 0 | 0 | $506275 | $402059 | $655000 | $373000 | $423000 | $1.1M | $772509 |
| Dette Nette | -$14.1M | -$11.8M | -$13.7M | -$13.6M | -$30.8M | -$40.6M | -$31.8M | -$34.5M | -$14.9M | -$6.4M |
| Fonds de Roulement | $10.4M | $12.6M | $11.6M | $6.1M | $31.0M | $42.2M | $31.7M | $33.9M | $12.2M | $1.0M |
Santé financière
| Dette / Capitaux propres | -0.07 |
| Ratio de liquidité | 1.35 |
Rentabilité
| Rentabilité des capitaux propres | 1020.21% |
| Rentabilité du capital investi | -1480.50% |
| Rentabilité des actifs | -498.10% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ATOS · CLNN · COYA · IMMX · MGNX · SRZN · TIL
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ONCY: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions